<?xml version="1.0" encoding="utf-8"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en"><title>The latest in Food and Drug Administration</title><link href="http://www.factsaboutheadaches.com/topic/Food%20and%20Drug%20Administration" rel="alternate"></link><id>http://www.factsaboutheadaches.com/topic/Food and Drug Administration</id><updated>2010-03-18T00:15:44Z</updated><entry><title>Feds Halt Marketing of Unapproved Nitroglycerin Tablets</title><link href="http://www.factsaboutheadaches.com/article/Feds%20Halt%20Marketing%20of%20Unapproved%20Nitroglycerin%20Tablets" rel="alternate"></link><updated>2010-03-18T00:15:44Z</updated><author><name>consumeraffairs.com</name></author><id>tag:www.factsaboutheadaches.com,2010-03-18:/article/Feds%20Halt%20Marketing%20of%20Unapproved%20Nitroglycerin%20Tablets</id><summary type="html">&amp;lt;div id="subtitle"&amp;gt;FDA says order will not affect supplies of heart medications&amp;lt;/div&amp;gt;&amp;lt;div&amp;gt;&amp;lt;p&amp;gt;The &lt;a title="Food and Drug Administration FDA" href="/topic/Food+and+Drug+Administration+FDA" &gt;Food and Drug Administration FDA&lt;/a&gt; has ordered Glenmark Generics of Mahwah, &lt;a title="New Jersey" href="/topic/New+Jersey" &gt;N.J.&lt;/a&gt;, and &lt;a title="Konec Inc." href="/topic/Konec+Inc." &gt;Konec Inc.&lt;/a&gt; of &lt;a title="Tucson" href="/topic/Tucson" &gt;Tucson&lt;/a&gt;, &lt;a title="Arizona" href="/top...</summary><category term="Health Care Issues"></category><category term="Prescription Drugs"></category><category term="Heart Attacks"></category><category term="Deborah Autor"></category><category term="Cardiovascular Medicine"></category><category term="Konec Inc."></category><category term="Food and Drug Administration FDA"></category></entry><entry><title>Delauro sees U.S. food safety law in 2010</title><link href="http://www.factsaboutheadaches.com/article/Delauro%20sees%20U.S.%20food%20safety%20law%20in%202010" rel="alternate"></link><updated>2010-03-17T14:45:52Z</updated><author><name>Reuters US Online Report Health News</name></author><id>tag:www.factsaboutheadaches.com,2010-03-17:/article/Delauro%20sees%20U.S.%20food%20safety%20law%20in%202010</id><summary type="html">&amp;lt;div&amp;gt;&amp;lt;p&amp;gt;WASHINGTON (&lt;a title="Reuters Group plc" href="/topic/Reuters+Group+plc" &gt;Reuters&lt;/a&gt;) - Congress will pass a new law to overhaul the antiquated U.S. food safety system by the end of the year, &lt;a title="Rosa DeLauro" href="/topic/Rosa+DeLauro" &gt;U.S. Rep. Rosa DeLauro&lt;/a&gt;, an influential House lawmaker, said on Wednesday.&amp;lt;/p&amp;gt;&amp;lt;p&amp;gt;The first major reform of the system in 50 years could be followed by another close look at how meat and poultry are inspected, and the cha...</summary><category term="Trade"></category><category term="Food and Cooking"></category><category term="Foods"></category><category term="Meat"></category><category term="Political Policy"></category><category term="International Relations"></category><category term="Trade Policy"></category><category term="Food Safety"></category><category term="Reuters Group plc"></category><category term="Barack Obama"></category><category term="World Trade Organization"></category><category term="Office of the United States Trade Representative"></category><category term="Rosa DeLauro"></category><category term="Richard Chang"></category><category term="Charles Abbott"></category></entry><entry><title>Prescription-drug heists on the rise</title><link href="http://www.factsaboutheadaches.com/article/Prescription-drug%20heists%20on%20the%20rise" rel="alternate"></link><updated>2010-03-17T14:30:19Z</updated><author><name>AP Features</name></author><id>tag:www.factsaboutheadaches.com,2010-03-17:/article/Prescription-drug%20heists%20on%20the%20rise</id><summary type="html">&amp;lt;div&amp;gt;&amp;lt;p&amp;gt;The $75 million heist at a pharmaceutical warehouse in &lt;a title="Connecticut" href="/topic/Connecticut" &gt;Connecticut&lt;/a&gt; this week was just the most audacious example of a growing phenomenon: Thieves are stealing large quantities of prescription drugs for resale on the black market.&amp;lt;/p&amp;gt;&amp;lt;p&amp;gt;Pharmaceutical heists in the &lt;a title="United States" href="/topic/United+States" &gt;U.S.&lt;/a&gt; have quadrupled since 2006, a coalition of industry and law enforcement estimates. And...</summary><category term="Crime"></category><category term="Burglary"></category><category term="Law Enforcement"></category><category term="Health Care Issues"></category><category term="Prescription Drugs"></category><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category><category term="Novo Nordisk AS"></category><category term="Steve Brozak"></category><category term="WBB Securities LLC"></category><category term="Purdue Pharma LP"></category><category term="Eric Tucker"></category><category term="FreightWatch International"></category><category term="Ron Greene"></category><category term="Charles Forsaith"></category></entry><entry><title>Boston Sci could resume ICD sales within 30 days</title><link href="http://www.factsaboutheadaches.com/article/Boston%20Sci%20could%20resume%20ICD%20sales%20within%2030%20days" rel="alternate"></link><updated>2010-03-17T11:45:47Z</updated><author><name>Reuters US Online Report Business News</name></author><id>tag:www.factsaboutheadaches.com,2010-03-17:/article/Boston%20Sci%20could%20resume%20ICD%20sales%20within%2030%20days</id><summary type="html">&amp;lt;div&amp;gt;&amp;lt;p&amp;gt;&lt;a title="Chicago" href="/topic/Chicago" &gt;CHICAGO&lt;/a&gt; (&lt;a title="Reuters Group plc" href="/topic/Reuters+Group+plc" &gt;Reuters&lt;/a&gt;) - &lt;a title="Boston Scientific Corporation" href="/topic/Boston+Scientific+Corporation" &gt;Boston Scientific Corp.&lt;/a&gt; &amp;amp;lt;BSX.N&amp;amp;gt; could be selling implantable heart rhythm devices again within 30 days if no new issues arise beyond the paperwork problems revealed this week.&amp;lt;/p&amp;gt;&amp;lt;p&amp;gt;"Our number one conclusion is ... that &lt;a title="B...</summary><category term="Technology"></category><category term="Medical Technology"></category><category term="Medical Devices"></category><category term="Medical Equipment and Supplies"></category><category term="Electromedical Apparatus Manufacturing"></category><category term="Reuters Group plc"></category><category term="Boston Scientific Corporation"></category><category term="Jude Thaddeus"></category><category term="St. Jude Medical Inc."></category><category term="Michael Weinstein"></category><category term="Paul Donovan"></category><category term="Susan Kelly"></category><category term="Derrick Sung"></category><category term="New York Stock Exchange"></category><category term="JPMorgan Chase &amp; Co."></category></entry><entry><title>Breast cancer study aims to speed drugs, cooperation</title><link href="http://www.factsaboutheadaches.com/article/Breast%20cancer%20study%20aims%20to%20speed%20drugs%2C%20cooperation" rel="alternate"></link><updated>2010-03-17T11:00:53Z</updated><author><name>Reuters US Online Report Health News</name></author><id>tag:www.factsaboutheadaches.com,2010-03-17:/article/Breast%20cancer%20study%20aims%20to%20speed%20drugs%2C%20cooperation</id><summary type="html">&amp;lt;div&amp;gt;&amp;lt;p&amp;gt;WASHINGTON (&lt;a title="Reuters Group plc" href="/topic/Reuters+Group+plc" &gt;Reuters&lt;/a&gt;) - Researchers launched a unique collaboration on Wednesday aimed at getting cancer drugs to the market more quickly in which three companies will cooperate with the &lt;a title="United States" href="/topic/United+States" &gt;U.S.&lt;/a&gt; government and non-profit groups to test five experimental breast cancer drugs.&amp;lt;/p&amp;gt;&amp;lt;p&amp;gt;The five-year, $26 million study called Investigation of Serial Stu...</summary><category term="Cancer"></category><category term="Breast Cancer"></category><category term="Clinical Trials"></category><category term="Medical Treatments and Procedures"></category><category term="Medical Drug Therapy"></category><category term="Technology"></category><category term="Medical Technology"></category><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category><category term="Women's Health"></category><category term="Reuters Group plc"></category><category term="Safeway Inc."></category><category term="F. Hoffman-La Roche Ltd."></category><category term="Pharmaceutical Research and Manufacturers of America"></category><category term="Abbott Laboratories Inc."></category><category term="John O'Callaghan"></category><category term="Anna Barker"></category><category term="Chemotherapy"></category><category term="Laura Esserman"></category><category term="Biomarkers Consortium"></category></entry><entry><title>Brazen Conn. warehouse heist nets $75M in pills</title><link href="http://www.factsaboutheadaches.com/article/Brazen%20Conn.%20warehouse%20heist%20nets%20%2475M%20in%20pills" rel="alternate"></link><updated>2010-03-16T18:45:22Z</updated><author><name>AP News</name></author><id>tag:www.factsaboutheadaches.com,2010-03-16:/article/Brazen%20Conn.%20warehouse%20heist%20nets%20%2475M%20in%20pills</id><summary type="html">&amp;lt;div id="subtitle"&amp;gt;$75M in prescription drugs stolen in brazen &lt;a title="Connecticut" href="/topic/Connecticut" &gt;Conn.&lt;/a&gt; heist; thieves rappelled into warehouse&amp;lt;/div&amp;gt;&amp;lt;div&amp;gt;&amp;lt;p&amp;gt;In a Hollywood-style heist, thieves cut a hole in the roof of a warehouse, rappelled inside and scored one of the biggest hauls of its kind — not diamonds, gold bullion or Old World art, but about $75 million in antidepressants and other prescription drugs.&amp;lt;/p&amp;gt;&amp;lt;p&amp;gt;The pills — stolen from ...</summary><category term="Crime"></category><category term="Burglary"></category><category term="Grand Larceny"></category><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category><category term="The Associated Press"></category><category term="Hartford (Connecticut)"></category><category term="Richmond (Virginia)"></category><category term="The Kroger Company"></category><category term="Springfield (Massachusetts)"></category><category term="The Brink's Company"></category><category term="Stephen Singer"></category><category term="Erik Gordon"></category><category term="Eric Tucker"></category><category term="Michelle Smith"></category><category term="Tom Murphy"></category><category term="CVS Caremark Corporation"></category><category term="Dan Burges"></category><category term="FreightWatch International"></category><category term="Tom Gasparoli"></category></entry><entry><title>FDA eyes improvements for diabetics' glucose devices</title><link href="http://www.factsaboutheadaches.com/article/FDA%20eyes%20improvements%20for%20diabetics%27%20glucose%20devices" rel="alternate"></link><updated>2010-03-16T14:33:04Z</updated><author><name>Reuters US Online Report Health News</name></author><id>tag:www.factsaboutheadaches.com,2010-03-16:/article/FDA%20eyes%20improvements%20for%20diabetics%27%20glucose%20devices</id><summary type="html">&amp;lt;div&amp;gt;&amp;lt;p&amp;gt;&lt;a title="Gaithersburg" href="/topic/Gaithersburg" &gt;GAITHERSBURG&lt;/a&gt;, &lt;a title="Maryland" href="/topic/Maryland" &gt;Maryland&lt;/a&gt; (&lt;a title="Reuters Group plc" href="/topic/Reuters+Group+plc" &gt;Reuters&lt;/a&gt;) - U.S. health regulators are taking a closer look at how well devices used by diabetics to monitor their blood sugars work, seeking possible changes for device makers to help make them more reliable.&amp;lt;/p&amp;gt;&amp;lt;p&amp;gt;At a two-day meeting to review blood glucose meters, &lt;a tit...</summary><category term="Internal Medicine"></category><category term="Metabolic Disorders"></category><category term="Diabetes"></category><category term="Technology"></category><category term="Medical Technology"></category><category term="Medical Devices"></category><category term="Reuters Group plc"></category><category term="Advanced Medical Technology Association"></category><category term="Jeffrey Shuren"></category><category term="Barry Ginsberg"></category><category term="Courtney Harper"></category><category term="Steve Brotman"></category></entry><entry><title>FDA critiques Medtronic's MRI-compatible pacemaker</title><link href="http://www.factsaboutheadaches.com/article/FDA%20critiques%20Medtronic%27s%20MRI-compatible%20pacemaker" rel="alternate"></link><updated>2010-03-16T13:34:24Z</updated><author><name>AP Features</name></author><id>tag:www.factsaboutheadaches.com,2010-03-16:/article/FDA%20critiques%20Medtronic%27s%20MRI-compatible%20pacemaker</id><summary type="html">&amp;lt;div&amp;gt;&amp;lt;p&amp;gt;The &lt;a title="Food and Drug Administration" href="/topic/Food+and+Drug+Administration" &gt;Food and Drug Administration&lt;/a&gt; voiced several complaints Tuesday with &lt;a title="Medtronic Inc." href="/topic/Medtronic+Inc." &gt;Medtronic&lt;/a&gt;'s study of a new pacemaker that can be used in an MRI machine.&amp;lt;/p&amp;gt;&amp;lt;p&amp;gt;Patients with pacemakers are generally discouraged from having MRI scans because the radio waves could interfere with the functioning of their device.&amp;lt;/p&amp;gt;&amp;lt;p&amp;gt;...</summary><category term="Medical Treatments and Procedures"></category><category term="Technology"></category><category term="Medical Technology"></category><category term="Medical Devices"></category><category term="Medical Equipment and Supplies"></category><category term="Electromedical Apparatus Manufacturing"></category><category term="Medical Imaging and Diagnostics"></category></entry><entry><title>Clarification: Amylin FDA info request story</title><link href="http://www.factsaboutheadaches.com/article/Clarification%3A%20Amylin%20FDA%20info%20request%20story" rel="alternate"></link><updated>2010-03-16T13:31:00Z</updated><author><name>AP News</name></author><id>tag:www.factsaboutheadaches.com,2010-03-16:/article/Clarification%3A%20Amylin%20FDA%20info%20request%20story</id><summary type="html">&amp;lt;div id="subtitle"&amp;gt;Clarification: &lt;a title="Amylin FDA" href="/topic/Amylin+FDA" &gt;Amylin FDA&lt;/a&gt; information request story&amp;lt;/div&amp;gt;&amp;lt;div&amp;gt;&amp;lt;p&amp;gt;In a story March 15, &lt;a title="The Associated Press" href="/topic/The+Associated+Press" &gt;The Associated Press&lt;/a&gt; reported that Bydureon is the proposed trade name of exenatide, a diabetes treatment being developed by &lt;a title="Amylin Pharmaceuticals Inc." href="/topic/Amylin+Pharmaceuticals+Inc." &gt;Amylin Pharmaceuticals Inc.&lt;/a&gt;, &lt;a titl...</summary><category term="Internal Medicine"></category><category term="Metabolic Disorders"></category><category term="Diabetes"></category><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category><category term="The Associated Press"></category><category term="Byetta"></category><category term="Novo Nordisk AS"></category><category term="Alkermes Inc."></category><category term="Amylin Pharmaceuticals Inc."></category></entry><entry><title>FDA questions new use for Boston Science device</title><link href="http://www.factsaboutheadaches.com/article/FDA%20questions%20new%20use%20for%20Boston%20Science%20device" rel="alternate"></link><updated>2010-03-16T11:46:01Z</updated><author><name>AP Features</name></author><id>tag:www.factsaboutheadaches.com,2010-03-16:/article/FDA%20questions%20new%20use%20for%20Boston%20Science%20device</id><summary type="html">&amp;lt;div&amp;gt;&amp;lt;p&amp;gt;The &lt;a title="Food and Drug Administration" href="/topic/Food+and+Drug+Administration" &gt;Food and Drug Administration&lt;/a&gt; said Tuesday a heart device from &lt;a title="Boston Scientific Corporation" href="/topic/Boston+Scientific+Corporation" &gt;Boston Scientific&lt;/a&gt; appears effective for a new group of patients, though questions remain about the accuracy of the company's study of the device.&amp;lt;/p&amp;gt;&amp;lt;p&amp;gt;Boston Scientific has asked the FDA to approve its heart rhythm device t...</summary><category term="Technology"></category><category term="Medical Technology"></category><category term="Medical Devices"></category><category term="Boston Scientific Corporation"></category><category term="St. Jude Medical Inc."></category><category term="Natick"></category><category term="Cardiovascular Medicine"></category></entry><entry><title>What is Tylenol?</title><link href="http://www.factsaboutheadaches.com/article/What%20is%20Tylenol%3F" rel="alternate"></link><updated>2010-03-16T14:07:33Z</updated><author><name>isnare</name></author><id>tag:www.factsaboutheadaches.com,2010-03-16:/article/What%20is%20Tylenol%3F</id><summary type="html">&lt;p&gt;&amp;lt;B&amp;gt;Information about &lt;a title="Tylenol" href="/topic/Tylenol" &gt;Tylenol&lt;/a&gt;&amp;lt;/B&amp;gt;&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;Don't use more than the recommended ammount. An overdose of acetaminophen can cause serious damage. The highest amount of acetaminophen for grown up person is one gram (1000 mg) per dose and four grams (4000 mg) daily. Taking more acetaminophen could damage the liver. If you drink more than three drinks per day, talk to your family doctor before taking acetaminophen and don't use more...</summary><category term="Family"></category><category term="Pregnancy and Childbirth"></category><category term="Family Medicine"></category><category term="Internal Medicine"></category><category term="Liver Diseases"></category></entry><entry><title>FDA seeks more data on MannKind's inhaled insulin</title><link href="http://www.factsaboutheadaches.com/article/FDA%20seeks%20more%20data%20on%20MannKind%27s%20inhaled%20insulin" rel="alternate"></link><updated>2010-03-16T00:15:14Z</updated><author><name>Reuters US Online Report Health News</name></author><id>tag:www.factsaboutheadaches.com,2010-03-16:/article/FDA%20seeks%20more%20data%20on%20MannKind%27s%20inhaled%20insulin</id><summary type="html">&amp;lt;div&amp;gt;&amp;lt;p&amp;gt;BOSTON (&lt;a title="Reuters Group plc" href="/topic/Reuters+Group+plc" &gt;Reuters&lt;/a&gt;) - &lt;a title="United States" href="/topic/United+States" &gt;U.S.&lt;/a&gt; regulators have requested more information on an inhaled insulin device being developed by &lt;a title="MannKind Corporation" href="/topic/MannKind+Corporation" &gt;MannKind Corp&lt;/a&gt;, sending the company's shares down 24.7 percent.&amp;lt;/p&amp;gt;&amp;lt;p&amp;gt;MannKind said on Monday that it had received a so-called complete response letter from t...</summary><category term="Technology"></category><category term="Medical Technology"></category><category term="Medical Devices"></category><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category><category term="Reuters Group plc"></category><category term="Novo Nordisk AS"></category><category term="Humalog"></category><category term="Exubera"></category><category term="John Wallace"></category><category term="Gary Hill"></category><category term="MannKind Corporation"></category><category term="Alfred Mann"></category><category term="NovoLog"></category><category term="Toni Clarke"></category><category term="Hapoalim Securities USA Inc."></category></entry><entry><title>Boston Scientific suspends defibrillator sales</title><link href="http://www.factsaboutheadaches.com/article/Boston%20Scientific%20suspends%20defibrillator%20sales" rel="alternate"></link><updated>2010-03-15T16:30:12Z</updated><author><name>AP Features</name></author><id>tag:www.factsaboutheadaches.com,2010-03-15:/article/Boston%20Scientific%20suspends%20defibrillator%20sales</id><summary type="html">&amp;lt;div&amp;gt;&amp;lt;p&amp;gt;Medical device maker &lt;a title="Boston Scientific Corporation" href="/topic/Boston+Scientific+Corporation" &gt;Boston Scientific&lt;/a&gt; said Monday it is suspending sales of its heart-shocking defibrillator implants after failing to alert regulators to changes in manufacturing of the best-selling devices.&amp;lt;/p&amp;gt;&amp;lt;p&amp;gt;The company said it uncovered two production changes that were not cleared with the &lt;a title="Food and Drug Administration" href="/topic/Food+and+Drug+Administrat...</summary><category term="Technology"></category><category term="Medical Technology"></category><category term="Medical Devices"></category><category term="Medical Equipment and Supplies"></category><category term="Electromedical Apparatus Manufacturing"></category><category term="Boston Scientific Corporation"></category><category term="The Associated Press"></category><category term="Jude Thaddeus"></category><category term="David Lewis"></category><category term="Sanford C. Bernstein &amp; Co. LLC"></category><category term="St. Jude Medical Inc."></category><category term="Natick"></category><category term="Tom Murphy"></category><category term="Cardiovascular Medicine"></category></entry><entry><title>Adding fat-lowering drug no help for diabetic hearts</title><link href="http://www.factsaboutheadaches.com/article/Adding%20fat-lowering%20drug%20no%20help%20for%20diabetic%20hearts" rel="alternate"></link><updated>2010-03-15T13:16:11Z</updated><author><name>Reuters US Online Report Health News</name></author><id>tag:www.factsaboutheadaches.com,2010-03-15:/article/Adding%20fat-lowering%20drug%20no%20help%20for%20diabetic%20hearts</id><summary type="html">&amp;lt;div&amp;gt;&amp;lt;p&amp;gt;&lt;a title="Atlanta" href="/topic/Atlanta" &gt;ATLANTA&lt;/a&gt; (&lt;a title="Reuters Group plc" href="/topic/Reuters+Group+plc" &gt;Reuters&lt;/a&gt;) - Adding a drug that lowers blood fats known as triglycerides to cholesterol-fighting statins provided no additional protection from heart attack, stroke and death from heart disease in patients with Type 2 diabetes, according to data from a large study.&amp;lt;/p&amp;gt;&amp;lt;p&amp;gt;The study run by the &lt;a title="National Institutes of Health" href="/topic/Na...</summary><category term="Cholesterol"></category><category term="Vascular Disorders"></category><category term="High Blood Pressure"></category><category term="Internal Medicine"></category><category term="Metabolic Disorders"></category><category term="Diabetes"></category><category term="Type 2 Diabetes"></category><category term="Stroke"></category><category term="Reuters Group plc"></category><category term="Steven Nissen"></category><category term="Cardiovascular Medicine"></category><category term="Brain and Nerve Health"></category><category term="Eugene Sun"></category><category term="Henry Ginsberg"></category><category term="Denise Simons-Morton"></category></entry><entry><title>Tissue-freezing balloon beats drugs in ablation study</title><link href="http://www.factsaboutheadaches.com/article/Tissue-freezing%20balloon%20beats%20drugs%20in%20ablation%20study" rel="alternate"></link><updated>2010-03-15T10:17:45Z</updated><author><name>AFP Global Edition</name></author><id>tag:www.factsaboutheadaches.com,2010-03-15:/article/Tissue-freezing%20balloon%20beats%20drugs%20in%20ablation%20study</id><summary type="html">&amp;lt;div&amp;gt;&amp;lt;p&amp;gt;An experimental ablation therapy system that freezes heart tissue with a balloon catheter to treat a common heart rhythm disorder is far more effective than drug therapy, a study found Monday.&amp;lt;/p&amp;gt;&amp;lt;p&amp;gt;Researchers compared the safety and efficacy of the Arctic Front CryoAblation Catheter System produced by US firm &lt;a title="Medtronic Inc." href="/topic/Medtronic+Inc." &gt;Medtronic&lt;/a&gt; to drug therapy over at least one year in 245 patients in the &lt;a title="United States...</summary><category term="Medical Treatments and Procedures"></category><category term="Medical Drug Therapy"></category><category term="Medical Equipment and Supplies"></category><category term="Electromedical Apparatus Manufacturing"></category><category term="Oceania"></category><category term="Cardiovascular Medicine"></category><category term="Douglas Packer"></category></entry><entry><title>Amylin shares up on FDA response for diabetes drug</title><link href="http://www.factsaboutheadaches.com/article/Amylin%20shares%20up%20on%20FDA%20response%20for%20diabetes%20drug" rel="alternate"></link><updated>2010-03-15T10:00:22Z</updated><author><name>AP News</name></author><id>tag:www.factsaboutheadaches.com,2010-03-15:/article/Amylin%20shares%20up%20on%20FDA%20response%20for%20diabetes%20drug</id><summary type="html">&amp;lt;div id="subtitle"&amp;gt;&lt;a title="Amylin Pharmaceuticals Inc." href="/topic/Amylin+Pharmaceuticals+Inc." &gt;Amylin Pharmaceuticals&lt;/a&gt; shares rise on FDA response for once-weekly diabetes drug&amp;lt;/div&amp;gt;&amp;lt;div&amp;gt;&amp;lt;p&amp;gt;Shares of Amylin Pharmaceuticals jumped 13 percent Monday as the &lt;a title="Food and Drug Administration" href="/topic/Food+and+Drug+Administration" &gt;Food and Drug Administration&lt;/a&gt; asked for more information on its potential diabetes treatment.&amp;lt;/p&amp;gt;&amp;lt;p&amp;gt;Amylin, along...</summary><category term="Financial Markets"></category><category term="Stock Performance"></category><category term="Internal Medicine"></category><category term="Metabolic Disorders"></category><category term="Diabetes"></category><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category><category term="Byetta"></category><category term="Novo Nordisk AS"></category><category term="Alkermes Inc."></category><category term="Amylin Pharmaceuticals Inc."></category><category term="Thomas Wei"></category><category term="Jim Birchenough"></category></entry><entry><title>BioSante cancer vaccine gets 'orphan drug' status</title><link href="http://www.factsaboutheadaches.com/article/BioSante%20cancer%20vaccine%20gets%20%27orphan%20drug%27%20status" rel="alternate"></link><updated>2010-03-15T10:00:21Z</updated><author><name>AP News</name></author><id>tag:www.factsaboutheadaches.com,2010-03-15:/article/BioSante%20cancer%20vaccine%20gets%20%27orphan%20drug%27%20status</id><summary type="html">&amp;lt;div id="subtitle"&amp;gt;FDA gives &lt;a title="BioSante Pharmaceuticals Inc." href="/topic/BioSante+Pharmaceuticals+Inc." &gt;BioSante&lt;/a&gt; pancreatic cancer treatment 'orphan drug' designation&amp;lt;/div&amp;gt;&amp;lt;div&amp;gt;&amp;lt;p&amp;gt;BioSante Pharmaceuticals has received orphan drug status for its potential pancreatic cancer treatment, the company said Monday.&amp;lt;/p&amp;gt;&amp;lt;p&amp;gt;The company said the &lt;a title="Food and Drug Administration" href="/topic/Food+and+Drug+Administration" &gt;Food and Drug Administration&lt;...</summary><category term="Cancer"></category><category term="Pancreatic Cancer"></category><category term="Clinical Trials"></category><category term="Medical Treatments and Procedures"></category><category term="Vaccines"></category><category term="Technology"></category><category term="Medical Technology"></category><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category><category term="Lincolnshire"></category><category term="BioSante Pharmaceuticals Inc."></category></entry><entry><title>Cryogenic balloon offers hope to heart patients</title><link href="http://www.factsaboutheadaches.com/article/Cryogenic%20balloon%20offers%20hope%20to%20heart%20patients" rel="alternate"></link><updated>2010-03-15T08:15:51Z</updated><author><name>AFP Global Edition</name></author><id>tag:www.factsaboutheadaches.com,2010-03-15:/article/Cryogenic%20balloon%20offers%20hope%20to%20heart%20patients</id><summary type="html">&amp;lt;div&amp;gt;&amp;lt;p&amp;gt;An experimental ablation therapy system that freezes heart tissue with a balloon catheter to treat a common heart rhythm disorder is far more effective than drug therapy, a study found Monday.&amp;lt;/p&amp;gt;&amp;lt;p&amp;gt;Researchers compared the safety and efficacy of the Arctic Front CryoAblation Catheter System produced by US firm &lt;a title="Medtronic Inc." href="/topic/Medtronic+Inc." &gt;Medtronic&lt;/a&gt; to drug therapy over at least one year in 245 patients in the &lt;a title="United States...</summary><category term="Medical Treatments and Procedures"></category><category term="Medical Drug Therapy"></category><category term="Medical Equipment and Supplies"></category><category term="Electromedical Apparatus Manufacturing"></category><category term="Oceania"></category><category term="Cardiovascular Medicine"></category><category term="Douglas Packer"></category></entry><entry><title>FDA To Reconsider Gay Blood Ban</title><link href="http://www.factsaboutheadaches.com/article/FDA%20To%20Reconsider%20Gay%20Blood%20Ban" rel="alternate"></link><updated>2010-03-15T07:30:43Z</updated><author><name>On Top Magazine</name></author><id>tag:www.factsaboutheadaches.com,2010-03-15:/article/FDA%20To%20Reconsider%20Gay%20Blood%20Ban</id><summary type="html">&amp;lt;div id="subtitle"&amp;gt;The Food &amp;amp;amp; Drug Administration (&lt;a title="Food and Drug Administration" href="/topic/Food+and+Drug+Administration" &gt;FDA&lt;/a&gt;) announced Friday it would reexamine its policy that bans gay men from donating blood&amp;lt;/div&amp;gt;&amp;lt;div&amp;gt;&amp;lt;p&amp;gt;  &amp;lt;p&amp;gt;The Food &amp;amp;amp; Drug Administration (FDA) announced Friday it would reexamine its policy that bans gay men from donating blood, the '&lt;a title="Los Angeles Times" href="/topic/Los+Angeles+Times" &gt;Los Angeles Times...</summary><category term="Relationships"></category><category term="Sexuality"></category><category term="Politics"></category><category term="Contagious and Infectious Diseases"></category><category term="HIV and AIDS"></category><category term="Hemophilia"></category><category term="Sexual and Reproductive Health"></category><category term="Sexually Transmitted Diseases"></category><category term="Los Angeles Times"></category><category term="John Kerry"></category><category term="Hamburg"></category><category term="Margaret Hamburg"></category><category term="Blood Disorders"></category><category term="Blood Transfusion and Donation"></category></entry><entry><title>Hair Restoration Methods</title><link href="http://www.factsaboutheadaches.com/article/Hair%20Restoration%20Methods" rel="alternate"></link><updated>2010-03-15T13:46:54Z</updated><author><name>isnare</name></author><id>tag:www.factsaboutheadaches.com,2010-03-15:/article/Hair%20Restoration%20Methods</id><summary type="html">&lt;p&gt;If you are losing your hair, regardless of whether it is just starting to thin or if you are developing bald patches, there are hair restoration methods that can help. Although there are a number of different methods for restoring hair, surgical methods are often the most effective. Of course, the method will depend on individual circumstances, as well as the amount of hair that has been lost, but most people find that surgical hair restoration is a lasting and reliable solution to the proble...</summary><category term="Fashion and Style"></category><category term="Hair Loss"></category><category term="Beauty and Hair Care"></category><category term="Hair Care and Styling"></category></entry></feed>